Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03582618
Title CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors TaiRx, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.